Below is the latest Dana email newsletter. You can sign up to receive this (and other Dana email alerts and/or print publications) by going here.
by Stephen G. Lisberger, Ph.D.
By all accounts, scientific misconduct over the last decade is on the rise, especially in the area of journal retractions. In neuroscience, our author — both a leading academic and an experienced neuroscience journal editor — believes the field is detecting “only the tip of the fraud iceberg.” His story addresses the nature, detection, and incentives for fraud, and suggests reforms. From Cerebrum, our online magazine of ideas.
The development of retinal prostheses to generate artificial vision for blind people is a complex, long-term, expensive,
and interdisciplinary undertaking. The FDA has approved the first such device and here’s how it works. One of our series of Reports on Progress.
Thanks to a century of memory research, we know a good deal about its operation: what happens in the brain when we store facts, experiences, and skills in memory; what happens when we recall them. One of our series of Primers.
Researchers hope that the ‘5:2 diet’ and other eating-restriction techniques can prevent age-related neurodegeneration and extend the working life of the brain.
The Law to Neuroscience: Hold Up
Much of what we “know” from neuroscience research is not ready — yet — for use in the courtroom, argued panelists during a forum April 25 in Washington, DC. A webcast from the Neuroscience and Law series, sponsored by the Dana Foundation, AAAS, The MacArthur Foundation Research Network on Law and Neuroscience, and the International Neuroethics Society.
See also: Dana blog: Write-up of the Neuroscience and the Law event